SCHEMBL5658371

SCHEMBL5658371

NC(=O)N(Cc1cnc(-c2ccccc2)s1)c1cccc2cnccc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FEN1 P39748 1/20 0.38
CYP11B1 P15538 3/20 0.38
CYP11B2 P19099 2/20 0.38
ROCK1 Q13464 1/20 0.37
NAMPT P43490 1/20 0.37
ALDH1A1 P00352 2/20 0.36
KMT2A Q03164 1/20 0.36
TRPV1 Q8NER1 2/20 0.36
CDC7 O00311 2/20 0.36
DBF4 Q9UBU7 2/20 0.36
CCNE1 P24864 1/20 0.36
CDK2 P24941 1/20 0.36
HDAC1 Q13547 2/20 0.36
HDAC2 Q92769 1/20 0.36
RAB9A P51151 2/20 0.35
NR2F2 P24468 1/20 0.35
NPC1 O15118 1/20 0.34
MAPT P10636 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MAPK8 P45983 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27642761 0.76 PTGER2 (0.41) ROCK1TRPV1RAB9ANR2F2MAPT
SCHEMBL5431368 0.75 ROS1 (0.51) ROCK1ALDH1A1TRPV1RAB9ANR2F2
SCHEMBL27642766 0.73 TRPV1 (0.43) ROCK1ALDH1A1KMT2ATRPV1MAPT
SCHEMBL9253552 0.72 ALOX5 (0.52) CYP11B1CYP11B2ALDH1A1HDAC1HDAC2
SCHEMBL6625347 0.72 TRPV1 (0.53) ROCK1TRPV1
SCHEMBL5411314 0.72 TRPV1 (0.53) TRPV1
SCHEMBL5658073 0.72 TRPV1 (0.41) ROCK1TRPV1RAB9ANR2F2HDAC6
SCHEMBL6623343 0.72 CYP3A4 (0.40) CYP11B1CYP11B2ROCK1ALDH1A1KMT2A
SCHEMBL27663654 0.72 TRPV1 (0.40) ROCK1TRPV1HDAC6
SCHEMBL5658084 0.71 L3MBTL1 (0.39) ROCK1ALDH1A1TRPV1RAB9ANR2F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7285563-B2 Heteroaromatic urea derivatives as VR-1 receptor modulators for treating pain MERCK SHARP & DOHME LTD. (GB) 2007-10-23 US disclosed
US-20050107388-A1 Heteroaromatic urea derivatives as vr-1receptor modulators for treating pain MERCK SHARP & DOHME LTD. (GB) 2005-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050107388-A1 Heteroaromatic urea derivatives as vr-1receptor modulators for treating pain ARRB1, OPRL1, CNR1 FEN1 2964/4885CYP11B1 687/4885CYP11B2 1030/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.